Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer
Clinical trial NCT00767520 · COMPLETED
Trial details
- NCT number
- NCT00767520
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2011-03-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.